Synthetic Lethal Screen Identifies NF-κB as a Target for Combination Therapy with Topotecan for patients with Neuroblastoma
Patricia Tsang(National Cancer Institute), Javed Khan(National Cancer Institute)
Cited by 17
Related Papers
Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models
|Journal of Clinical Investigation|2009|322
Clonality and Evolutionary History of Rhabdomyosarcoma
|PLoS Genetics|2015|76